1.Determination of Trace Arsenic in Cosmetics by Miniature Neutron Source Reactor Epithermal Neutron Activation Analysis
Ying ZHANG ; Weidong XU ; Daliang HUANG
Journal of Environment and Health 1992;0(05):-
98%. Conclusion This method was suitable for the determination of trace arsenic in cosmetics.
2.Evaluation of APACHE Ⅱ scoring system in severe acute pancreatitis
Yanchang CHEN ; Heguang HUANG ; Daliang CHEN ; Yaosong WU ; Jinhai ZHU
Chinese Journal of General Surgery 1993;0(03):-
Objective To investigate the effect of acute physiology and chronic health evaluationⅡ ( APACHEⅡ) scoring system on evaluating the severity and prognosis in severe acute pancreatitis(SAP). Methods The APACHEⅡ scores were analyzed in 52 patients with SAP. Results The mean APACHEⅡ score of SAP was 16.60?9.07(8~40), and there were significant differences between the scores not only in Grade SAPⅠand Grade SAPⅡ(?
3.Current Research of the Roles of IL-35 in Tumor Progression
HUANG CHONGBIAO ; TIAN YE ; CUI YAN ; XU JIE ; XIN LIANG ; YANG XUELING ; QI DALIANG
Chinese Journal of Lung Cancer 2016;19(4):230-235
Interleukin(IL)-35 is a new member of the interleukin-12 superfamily. Since its first report in 2007, IL-35 rapidly became a research highlight in the ifeld of immunology. Like other IL-12 superfamily members, IL-35 was a heterodimer which was composed of anαchain P35 and aβchain Epstein-Barr virus induced gene 3 (EBI3). Recent research work revealed two distinct roles of IL-35. Firstly, IL-35 is highly expressed in some kinds of inlfammatory diseases and autoim-mune diseases and plays import roles in the pathogenesis. Secondly, IL-35 is positively expressed in some cancers and plays some roles in the process of tumor progression. Here we demonstrate the structure and the signalling of IL-35. We reviewed the the roles of IL-35 in promoting tumor progression.
4. Brain glucose metabolism network and connectivity in patients with somatoform disorders
Zhiwei PAN ; Jianfei XIAO ; Qi HUANG ; Donglang JIANG ; Shuhua REN ; Yihui GUAN ; Fang XIE ; Daliang SUN ; Fengchun HUA
Chinese Journal of Nuclear Medicine and Molecular Imaging 2020;40(1):6-10
Objective:
To observe the alteration of brain glucose metabolic network in patients with somatoform disorders (SFD).
Methods:
18F-fluorodeoxyglucose (FDG) PET images of 18 SFD patients (10 males, 8 females; age: (39.5±12.0) years; illness duration: (3.67±3.20) years) and 21 matched healthy controls (13 males, 8 females; age: (43.9±8.4) years) in Huashan Hospital of Fudan University from October 2011 to December 2012 were enrolled to construct the brain glucose metabolic networks for 2 groups (SFD group, control group) respectively. Then the global network properties (normalized clustering coefficient, normalized shortest path length, small-worldness and global efficiency) and local parameters (clustering coefficient and betweenness centrality of the node) were calculated using the graph theory. Differences between 2 groups were compared by permutation test with 1 000 permutations. The top 20% (18/90) were classified as Hub nodes based on the results of clustering coefficient and betweenness centrality of the node.
Results:
Small-worldness of SFD patients was similar to that of healthy controls (